UT Health San Antonio

7703 Floyd Curl Drive, MC 7810
San Antonio TX 78229
+1 210-562-9149 (coordinator)
+1 210-743-2300 (clinic)
+1 210-567-7477 (administrative office)

UT Health physicians in partnership with UT Health San Antonio Cancer Therapy and Research Center and the University Health System have created a comprehensive pediatric medical center serving South Central Texas. For over thirty years the Division of Pediatric Hematology-Oncology has provided care to infants, children, adolescents and young adults affected by blood and cancer disorders.

Our faculty is involved in all phases of therapeutic trials, symptom management trials, behavioral research and survivorship care research. Research focused on the causes and treatment of childhood cancer as well as research focused on understanding and reducing the impact of cancer treatment on cancer survivors are supported through the Greehey Children's Cancer Research Institute and the Institute for Drug Development.

We believe that improvement in cancer survival can only be achieved through research starting from pre-clinical discovery and testing, to all phases and types of clinical trials. We also believe that no patient should be denied access to novel therapies based on socio-economic factors. To this effect, we support a portion of the clinical research infrastructure at four regional pediatric oncology programs in South Texas through the STP-NCORP grant to allow patients to be treated on clinical trials in their community.

Research Team

Principal Investigator

Anne-Marie Langevin, MD

Professor of Pediatrics

Dr. Langevin's strengths as a board-certified pediatric oncologist, a Canadian board-certified adult hematologist, the institutional PI for COG, PI of the South Texas Pediatric NCORP, and institutional PI for POETIC are to identify gaps in clinical cancer research relevant to children, adolescents and young adults. She has been active in POG and COG as study chair for Phase I and II studies and continue to serve on many COG committees. As NCORP PI, she has served on many NCI committees and Task Force groups and is currently serving a 5-year term on the NCI Clinical Trials and Translational Research Advisory Committee (CTAC).

"Innovation, whether a new drug or a new way of delivering old ones, is at the core of what I do... I am a strong advocate of soundly designed clinical trials to advance the science and improve cancer patients’ outcome."

-Dr. Anne-Marie Langevin

The staff at UT Health San Antonio

* indicates required

Join our quarterly newsletter

Receive updates on POETIC new projects and activities.

 Pediatric Oncology Experimental Therapeutics Investigators' Consortium

© Copyright 2023  |   Website designed by Amanda M. Buckley


(650) 736-0269